Sat. Sep 30th, 2023
Molecular Biology Enzymes, Kits, and Reagents Market Worth $41.10Bn, Globally, by 2028 at 17.8% CAGR Lead by Kits & Reagents Segment: The Insight Partners

The molecular biology enzymes, kits, and reagents market size was valued at $10.98 billion in 2020 and it is projected to reach $41.10 billion by 2028; it is expected to grow at a CAGR of 17.8% from 2021 to 2028.

/EIN News/ — New York, May 26, 2022 (GLOBE NEWSWIRE) — The Insight Partners published latest research study on “Molecular Biology Enzymes, Kits, and Reagents Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product (Enzymes and Kits & Reagents), Application (Epigenetics, Sequencing, Synthetic Biology, Polymerase Chain Reaction, Cloning, and Other), and End User (Biotechnological & Pharmaceutical Companies, Hospitals & Diagnostic Centers, and Academic & Research Institutes)”, the global molecular biology enzymes, kits, and reagents market growth is driven by the healthy funding for genomics, declining cost of sequencing procedures, and increasing prevalence of chronic diseases. However, the dearth of skilled professionals is hindering the market’s growth to some extent.

The Sample Pages Showcases Content Structure and Nature of Information Included in This Research Study Which Presents A Qualitative and Quantitative Analysis:

Report Coverage Details
Market Size Value in US$ 10.98 Billion in 2020
Market Size Value by US$ 41.10 Billion by 2028
Growth rate CAGR of 17.8% from 2021 to 2028.
Forecast Period 2021-2028
Base Year 2021
No. of Pages 142
No. Tables 137
No. of Charts & Figures 87
Historical data available Yes
Segments covered Product, Application, and End User
Regional scope North America; Europe; Asia Pacific; Latin America; MEA
Country scope US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Global Molecular Biology Enzymes, Kits & Reagents Market: Competition Landscape and Key Developments
THERMO FISHER SCIENTIFIC INC, Illumina, Inc., Qiagen, Agilent Technologies, Inc., F. HOFFMANN-LA ROCHE LTD, Merck KGAA, Jena Bioscience GmbH, Bioline Technologies, Promega Corporation, and Rockland Immunochemicals Inc. are the key companies operating in the molecular biology enzymes, kits & reagents market.

Schedule A Pre-Sale Discussion with The Author Team in A Slot That You Prefer to Address Queries on Scope of The Study, Customization, Introduction to Research Methodology, Assistance on Technologies and Market Definitions:

Market leaders are focusing on new product launches, expansion and diversification, and acquisition strategies, which allow them to tap into prevailing business opportunities. For instance, in April 2021, Promega Corporation announced the opening of Kornberg Center, the biotech company’s newly constructed research and development facility on its Fitchburg, WI campus. The facility will support core product and technology development in life science research, cellular and molecular biology, genetic identity, clinical diagnostic and scientific applications, and training.

North America secures the key share of the global molecular biology enzymes, kits & reagents market. The rapid sequencing technologies, increasing preference for personalized medicine, increasing competition between the market player, high R&D spending to develop new sequencing products, and sophisticated infrastructure are projected to accelerate the growth of this market over the forecast period. Moreover, the rise in the development and research for genomics and the rise in the programs for genomics in the region are propelling the North America molecular biology enzymes, kits & reagents market’s expansion.

Based on product, the global molecular biology enzymes, kits & reagents market is segmented into enzymes, kits and reagents. In 2020, the kits and reagents segment held the largest share of the market. It is further expected to retain its dominance over the forecast period. Growth in this segment can be attributed to the increasing adoption of analyzing instruments for sequencing by pharmaceutical and biopharmaceutical companies in advanced economies. Moreover, kits and reagents are expected to register the highest CAGR in the market between 2021 and 2028.

Click Here to Avail Lucrative DISCOUNTS on Our Latest Research Reports. We Offer Student, Enterprise, and Special Periodic Discounts to Our Clientele. Please Fill the Form to Know DISCOUNTED PRICE

Genome sequencing was restricted to the research facilities, a few years back. However, it has now became one of the common techniques in clinical practices. Over the next few years, the healthcare sector is expected to generate genomic data of over 60 million patients. The growing implementation of genomic sequencing into healthcare systems is supported by substantial government investments, totaling over US$ 4 billion in at least 14 countries.

The UK has announced the world’s largest genome project as part of 200 million public–private collaboration between charitable organizations and pharmaceutical companies. The country has already developed the world’s largest genome database through the 100,000 Genomes Project. Led by Innovate UK, a part of UK Research and Innovation, the project was initiated to support researchers and industries through funds to combine data and real-world evidence obtained from UK health services as well as to create new products and services for more efficient and early disease diagnosis.

In April 2020, MedGenome, a genetic diagnostics, research, and data company headquartered in Bengaluru, India, raised US$ 55 million (~INR 419 crore) in a new round of funding, led by LeapFrog Investments, a global impact investment firm. MedGenome also claims to have built the largest database of South Asian genetic variants in genetic diagnostics in India and research partnerships. It has conducted over 200,000 genomic tests to date by obtaining samples from more than 550 hospitals and 6,000 clinicians across India.

Have A 15-Minute-Long Discussion with The Lead Research Analyst and Author of The Report in A Time Slot Decided by You. You Will Be Briefed About the Contents of The Report and Queries Regarding the Scope of The Document Will Be Addressed as Well:

Such continuous funding by the manufacturers and governments in the field of genomics is supporting the molecular biology enzymes, kits, and reagents market growth.

Molecular Biology Enzymes, Kits & Reagents Market: Segmental Overview

Product-based Insights:
By product, the molecular biology enzymes, kits & reagents market is segmented into enzymes, kits & reagents. The kits & reagents segment is further bifurcated into polymerases, ligases, reverse transcriptases, phosphatases, proteases and proteinases, restriction endonuclease, and other. The consumables segment dominated the market in 2020. It is anticipated to register the highest CAGR of 18.2% in the market during the forecast period.

Application-based Insights:
The molecular biology enzymes, kits & reagents market, by application, is segmented into epigenetics, sequencing, synthetic biology, polymerase chain reaction, cloning, and others. The sequencing segment held the largest market share in 2020. However, polymerase chain reaction is anticipated to register a CAGR of 18.9% in the market during the forecast period.

Immediate Delivery of Our Off-The-Shelf Reports and Latest Research Studies, Through Flexible and Convenient Payment Methods:

End User-based Insights
Based on end user, the molecular biology enzymes, kits & reagents market is segmented into biotechnological and pharmaceutical companies, hospitals and diagnostic centers, academic and research institutes. The biotechnological and pharmaceutical companies segment held the largest share of the market in 2020 and is estimated to register the highest CAGR of 19.7% in the market during the forecast period.

Browse Adjoining Reports:
Diagnostic Specialty Enzymes Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product (Polymerases and Nucleases, Carbohydrases, Proteases, Oxidases, Ligases, Others); Application (Molecular Diagnostics, Clinical Chemistry, Research Studies, Others); End User (Pharamceutical and Biotechnological Companies, Hospitals and Clinical Laboratories, Diagnostic Laboratories, Research Institutes) and Geography

Epigenetics Market Forecast to 2025 – COVID-19 Impact and Global Analysis – by Product (Reagents, Kits, Enzymes, Instruments & Consumables, and Bioinformatics Tools), Technology (Histone Modification, DNA Methylation, and Others), Application (Oncology, Cardiovascular Diseases, and Others) End Users (Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organization)         

Human Microbiome Sequencing Technology Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Type (Traditional Sequencing Technologies, Next-Generation Sequencing, Third Generation Sequencing); End User (Research and Academic Institutions, Pharmaceutical and Biotechnology Companies, Others) and Geography

DNA Sequencing Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product (Consumable, Instrument, Service); Application (Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Forensics, Others); Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single-molecule Real-time Sequencing, Chain Termination Sequencing, Nanopore Sequencing); End User (Academic and Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals and Clinics) and Geography

Synthetic Biology Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Products (Enzymes, Chassis Organisms, Oligonucleotides, and Xeno-Nucleic Acids), Technology (Measurement & Modeling, Cloning & Sequencing, Genome Engineering, Gene Synthesis, Nanotechnology, and Others), and Application (Medical Applications, Industrial Applications, Food and Agriculture, Environmental Applications, and Others)

Synthetic Biology Technology Market Forecast to 2028 – COVID-19 Impact and Global Analysis ByType (Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Cloning, Site-Directed Mutagenesis, Microfluidics, Nanotechnology); Application (Medical, Industrial, Food and Agriculture, Others) and Geography

Polymerase Chain Reaction Technologies Market Forecast to 2028 – Covid-19 Impact and Global Analysis – by Technology (Real-Time PCR, Traditional PCR, Digital PCR); Products (Reagents and Kits, Instruments, Software, Services); End User (Diagnostic Centers, Hospitals, Research Institutes)

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876
Press Release:

Primary Logo

Article originally published at

originally published at Science - Reality Syndicate Viewers